COMPOSITION FOR PREVENTING OR TREATING PULMONARY FIBROSIS, COMPRISING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 27, 2025
app pub date -
Oct 4, 2024
filing date -
Oct 4, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to a composition for the prevention or treatment of pulmonary fibrosis, comprising a pharmaceutically acceptable salt of taurodeoxycholic acid as an active ingredient. Specifically, it has been confirmed that administration of a pharmaceutically acceptable salt of taurodeoxycholic acid results in a reduction of pulmonary fibrosis and the expression of pulmonary fibrosis-related factors in both an idiopathic pulmonary fibrosis animal model and a pulmonary fibrosis cell model. Therefore, taurodeoxycholic acid or a pharmaceutically acceptable salt thereof can be utilized as an active ingredient in a composition for the prevention or treatment of pulmonary fibrosis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully